<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><condition>Rectal Neoplasms</condition><condition>Colorectal cancer</condition><condition>Locally Advanced Rectal Cancer</condition><disease>Rectal Neoplasms</disease><disease>Colorectal Cancer</disease><disease>Locally Advanced Rectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/13467</full_dataset_link><study_start_month>4</study_start_month><keyword>TME surgery</keyword><keyword>Oxaliplatin</keyword><keyword>Capecitabine</keyword><keyword>Pelvic short-course radiotherapy</keyword><keyword>AK104</keyword><keyword>PCR</keyword><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13）</name><description>This study is a single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of preoperative short-course radiotherapy combined with AK104 and chemotherapy + TME surgery in patients with advanced rectal cancer.</description><dates><creation>2023-04-15</creation></dates><accession>13467</accession><cross_references><ClinicalTrials___gov>NCT05794750</ClinicalTrials___gov></cross_references></HashMap>